XBI
ETF
Biotechnology
NYSEARCA
SPDR S&P Biotech ETF
$121.70
+1.39 (+1.16%)
Fund Overview
by SPDR (State Street)
Equal-weighted biotech ETF. Gives small-cap clinical-stage biotech companies equal weight with large-cap pharma-like biotechs, creating a higher risk/reward profile. When biotech M&A heats up, XBI often outperforms.
AUM$6.5B
Expense Ratio0.35%
Holdings145
Dividend Yield0.1%
DistributionQuarterly
BenchmarkS&P Biotechnology Select Industry Index
InceptionJan 2006
ExchangeNYSEARCA
Price Data
Open$121.85
Prev Close$120.31
Day Range$120.95 — $123.28
Investment Calculator
See how much dividend income XBI could generate based on its current price of $121.70 and 0.1% yield. Adjust the amount to estimate your quarterly distributions.
$
Shares Purchased
Amount Invested$9,979.40
Annual Income$9.98
Monthly Income$0.83
Based on current dividend yield of 0.1%. Actual distributions may vary. Past dividends do not guarantee future payments.
Biotechnology ETF Comparison
Top Biotechnology Stocks
View all →
| Stock | Price | Change | Market Cap |
|---|---|---|---|
| ABBV | $211.12 | +1.90% | 397.77B |
| AMGN | $353.16 | -0.22% | 188.06B |
| GILD | $136.88 | -1.00% | 170.34B |
| VRTX | $453.74 | -0.27% | 115.53B |
| REGN | $756.73 | +0.97% | 80.50B |
| ALNY | $328.16 | -0.16% | 43.84B |
| INSM | $147.60 | -0.48% | 30.09B |
| NTRA | $196.15 | -0.62% | 27.94B |
| BIIB | $191.06 | +0.99% | 26.64B |
| UTHR | $532.53 | -1.67% | 20.54B |
XBI FAQ
What is XBI?
XBI is the SPDR S&P Biotech ETF, an exchange-traded fund managed by SPDR (State Street). It tracks the S&P Biotechnology Select Industry Index and holds 145 Biotechnology securities with an expense ratio of 0.35%.
What is the expense ratio of XBI?
XBI charges an annual expense ratio of 0.35%, which means you pay $35.00 per year for every $10,000 invested. This fee is deducted automatically from the fund's returns.
Does XBI pay dividends?
Yes, XBI pays a 0.1% dividend yield, distributed quarterly. On a $10,000 investment, that works out to approximately $10.00 per year in dividend income.
Explore Biotechnology Stocks
View our full list of individual biotechnology stocks with prices, fundamentals, and analyst ratings.
Last updated: Mar 23, 2026 at 10:16 PM ET